Ibrahim Saleh Alawadi

Dr. Ibrahim Saleh Alawadi

orcid

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 January 2025 in Neurosurgical Review
Verified
Journal Article
Open access
PDF file
YMYoustina Mohsen
Youstina Mohsen
Khalid SarhanKhalid Sarhan
Khalid Sarhan
IAIbrahim Saleh Alawadi
Ibrahim Saleh Alawadi
REReem Reda Elmahdi
Reem Reda Elmahdi
YKYasmeena Abdelall Kozaa
Yasmeena Abdelall Kozaa
MSMostafa Shahein
Mostafa Shahein
Epilepsy is a common neurological disease that is treated with medications; however, patients with drug-resistant epilepsy, commonly intractable temporal lobe epilepsy, tend to have better control with surgical treatment. While the mainstay of surgical treatment is anterior temporal lobectomy, it carries risk of potential adverse effects hence minimally invasive techniques are now being used as an alternative to open surgery. This systematic review and meta-analysis compare the efficacy and safety of three of the most used techniques: laser interstitial thermal therapy (LITT), radiofrequency ablation (RFA) and stereotactic radiosurgery (SRS). Multiple databases were searched and PRISMA guidelines were followed to make an indirect meta-analysis using the currently available studies for the three techniques in terms of seizure freedom, risk of major complications and reoperations. Further subgroup analyses were carried out for LITT in terms of follow up periods and seizure freedom in patients with or without hippocampal sclerosis. A total of 42 papers were included in this study with a total of 1675 patients (1303 treated by LITT, 188 treated by RFA and 184 treated by SRS). LITT had the highest rate of seizure freedom (55.0%, CI 51.5 − 58.5%, P = 0.148), and the lowest rates of major complications (2.3%, CI 1.2 − 3.5%, P = 0.070), and reoperations (14.3%, CI 10.4 − 18.3%, P = 0.042) compared to RFA and SRS which had seizure freedom of 46.3% (CI 18.8 − 73.7%, P = 0.000) and 53.8% (CI 44.4 − 63.3%; I^2 = 40.4%, P = 0.098), major complication rate of 3.9% (CI 0.7 − 7.0%; I^2 = 0%, P = 0.458) and 14.3% (CI 3.1 − 25.5%, P = 0.000) and reoperation rate of 28.6% (CI -4.3 − 61.5%, P = 0.000) and 15.4% (CI 6.1 − 24.8%; I^2 = 0%, P = 0.392) respectively. In conclusion, LITT showed the highest rate of seizure freedom and the lowest rate of major complications and reoperations compared to RFA and SRS in single-arm studies of intractable mesial temporal lobe epilepsy. However, the lack of direct comparisons between treatment modalities limits definitive conclusions. Despite this, LITT appears to offer a favorable safety profile, warranting further prospective, comparative studies to validate these findings.

10 March 2026 in Critical Reviews in Oncology/Hematology
Verified
Journal Article
Closed access
ABAhmed Reda Bahr
Ahmed Reda Bahr
IAIbrahim Saleh Alawadi
Ibrahim Saleh Alawadi
LALaila Mohamed Akr
Laila Mohamed Akr
Basant Atef AhmedBasant Atef Ahmed
Basant Atef Ahmed
Jaber H. JaradatJaber H. Jaradat
Jaber H. Jaradat
OHOmar Hamdy
Omar Hamdy